1. Neurological and neuropsychiatric manifestations of tuberous sclerosis complex
   Petrus de Vries, South Africa
2. Current treatments and emerging therapies for TSC-related seizures
   Paolo Curatolo, Italy
3. Potential of early intervention on improving neurological outcomes
   Anna Jansen, Belgium

Sponsored lunch symposium 4 – Emerging Findings for CLN2 Disease Early Diagnosis and Management – At the Intersection of Epilepsy and Genetics
Room: Emerald Room
BioMarin Pharmaceutical

1. CLN2 Disease and the Need for Early Diagnosis
   Ruth Williams, United Kingdom
2. Insights into Natural History and Strategies to Optimise Patient Outcomes
   Angela Schulz, Germany
3. Low Frequency IPS EEG – A Clue for Early Diagnosis
   Nicola Specchio, Italy

1. A needle in a haystack: differential diagnosis of NP-C in the paediatric population
   Charles Lourenço, Brazil
2. From NP-C suspicion to clinical practice
   Julian Raiman, United Kingdom
3. Latest advances in NP-C diagnosis: building on biomarkers
   Peter Clayton, United Kingdom
4. After diagnosis: treatment and monitoring of the disease
   Marc Patterson, U.S.A.

Sponsored lunch symposium 4 – Prolonged Seizures: Optimal Management of a Medical Emergency
Room: E104-E107
Shire

1. Introduction, Definitions and Epidemiology of Prolonged Seizures
   Emilio Perucca, Italy
2. Prolonged Seizures: Mechanisms of Action of Rescue Medications
   Steve White, U.S.A.
3. Pharmacological Treatment of Prolonged Seizures: Treating Epileptic Seizures by the Clock
   Helen Cross, United Kingdom
4. Burden of Uncontrolled Prolonged Seizures and Status Epilepticus
   Alexis Arzimanoglou, France

1. A typical journey in Duchenne muscular dystrophy: from diagnosis to referral and treatment
   Rosaline Quinlivan, United Kingdom
2. Why genetic testing is crucial for the accurate diagnosis of a patient with Duchenne muscular dystrophy
   Sylvie Tuffery-Giraud, France
3. What do the latest data tell us about the use of ataluren in the management of patients with nonsense mutation Duchenne muscular dystrophy?
   Eugenio Mercuri, Italy

1. The continuum of disease symptoms and diagnosis of SMA
   Ludo van der Pol, the Netherlands
2. Multidisciplinary management of patients with SMA
   Eugenio Mercuri and Elena Mazzone, Italy
3. The evolving SMA treatment landscape: what does the future hold?
   Susan Iannaccone, U.S.A.